dc.date.accessioned | 2021-03-23T21:36:14Z | |
dc.date.available | 2021-03-23T21:36:14Z | |
dc.date.created | 2020-11-24T11:20:20Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Lavelle, Timothy J Alver, Tine Norman Heintz, Karen Marie Wernhoff, Patrik Nygaard, Vegard Nakken, Sigve Øy, Geir Frode Bøe, Sigurd Urbanucci, Alfonso Hovig, Eivind . Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes. Cancers. 2020, 12(7), 1-20 | |
dc.identifier.uri | http://hdl.handle.net/10852/84616 | |
dc.description.abstract | The MC1R/cAMP/MITF pathway is a key determinant for growth, differentiation, and survival of melanocytes and melanoma. MITF-M is the melanocyte-specific isoform of Microphthalmia-associated Transcription Factor (MITF) in human melanoma. Here we use two melanocyte cell lines to show that forced expression of hemagglutinin (HA) -tagged MITF-M through lentiviral transduction represents an oncogenic insult leading to consistent cell transformation of the immortalized melanocyte cell line Hermes 4C, being a melanocortin-1 receptor (MC1R) compound heterozygote, while not causing transformation of the MC1R wild type cell line Hermes 3C. The transformed HA-tagged MITF-M transduced Hermes 4C cells form colonies in soft agar and tumors in mice. Further, Hermes 4C cells display increased MITF chromatin binding, and transcriptional reprogramming consistent with an invasive melanoma phenotype. Mechanistically, forced expression of MITF-M drives the upregulation of the AXL tyrosine receptor kinase (AXL), with concomitant downregulation of phosphatase and tensin homolog (PTEN), leading to increased activation of the PI3K/AKT pathway. Treatment with AXL inhibitors reduces growth of the transformed cells by reverting AKT activation. In conclusion, we present a model system of melanoma development, driven by MITF-M in the context of MC1R loss of function, and independent of UV exposure. This model provides a basis for further studies of critical changes in the melanocyte transformation process. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes | |
dc.type | Journal article | |
dc.creator.author | Lavelle, Timothy J | |
dc.creator.author | Alver, Tine Norman | |
dc.creator.author | Heintz, Karen Marie | |
dc.creator.author | Wernhoff, Patrik | |
dc.creator.author | Nygaard, Vegard | |
dc.creator.author | Nakken, Sigve | |
dc.creator.author | Øy, Geir Frode | |
dc.creator.author | Bøe, Sigurd | |
dc.creator.author | Urbanucci, Alfonso | |
dc.creator.author | Hovig, Eivind | |
cristin.unitcode | 185,53,2,15 | |
cristin.unitname | Senter for kreftcelle-reprogrammering | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1851512 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Cancers&rft.volume=12&rft.spage=1&rft.date=2020 | |
dc.identifier.jtitle | Cancers | |
dc.identifier.volume | 12 | |
dc.identifier.issue | 7 | |
dc.identifier.doi | https://doi.org/10.3390/cancers12071719 | |
dc.identifier.urn | URN:NBN:no-87329 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 2072-6694 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/84616/1/Dysregulation%2Bof%2BMITF%2BLeads%2Bto%2BTransformation%2Bin%2BMC1R-Defective%2BMelanocytes.pdf | |
dc.type.version | PublishedVersion | |
cristin.articleid | 1719 | |
dc.relation.project | KF/Tilskuddsnummer#198016-2018 | |